Lees - Bvvde

More documents

Recommendations

Info

' ( # 1 ' 7 -0 ' N C " - / 0 0 #' 2 BPN - - " 0 0 1" + - 0 0 # B B;;' 7 $' ( + 0 + 0 0 0 ' ( / 0 0 # + 1" 0 1 + 0 / ' 1 ) ## 7 < 3 0 1 0 0 4' + -" 0 1" + 0 - " ' • " # D - 0 ) / 1 1 # S < S # ' 8 B / 99 1; #1# #' & 0 / 1 ;#S' 8 0 - . #1 ' & / 1 1 - #S #' 8 + - 1 1 ' ( ' 8 - - S / 99 ' 8 + - - ) 1 1 0 # 1 1 0 ' @ ' ( 3B;;4 " 0 ' F + " # ' ( 0 - ' ( < " 0 ' 8 # + 8 . . "0 !! ' model 1 : G02 versus GNO model 3 : G02 versus G99 0,25 0,20 3! 2,31 3! 2,25 0,33 " 3 4,02 " 3 3,97 -1,44 0,68 model 2 : G02 versus G99 model 4 : G99 versus GNO 0,19 0,22 3! 2,38 0,27 3! 2,26 " 3 4,02 " 3 4,06 -1,16 '
#1# #' = -" + / 0 3 4 " -" / % 0 03 $ 4' 8 " 1 1" 0 "-- - ' aantal consultaties bij internist 4,0 3,5 3,0 2,5 2,0 ) - - 77 . - = , # . # < ) 1 • ( #! 3 8 3 8 7 , 33% 88% 3,3 3,8 ) ) 39% 85% 2,9 3,5 *7)&, 37% 86% 2,7 3,1 5/*( 36% 86% 2,9 3,3 (7 95% 94% 3,6 3,6 7)) 93% 92% 3,2 3,1 7* ) 92% 89% 2,9 2,8 /5( 93% 92% 3,3 3,2 */5(2 23% 22% 2,6 2,5 2001 2003 ( - 3 #4 - ' ( # 1< ' ( - < ' & + / " 0 ' G02 G99 GNO #
Page 2 and 3: ! " #$# % & """' ' ( " ) ' * +' ' ,
Page 4 and 5: III.4.2. Renale complicaties 51 III
Page 6 and 7: VI.22.1. diuretica en/of bèta-blok
Page 8 and 9: ++ ## ( + - 1+ 0 721 ), $ - - . / (
Page 10 and 11: ) • 8 $ +- 1 - - 0 ' • ( C " /
Page 12 and 13: ' 2 %' K ' K ' K ' ' K ' N ' H + P
Page 14 and 15: o - - ? o ? o ? o , , ? o , ? o , R
Page 16 and 17: ) 4 $ $ D # B B;; " 0 0 0 ' & 3B 4
Page 18 and 19: ( 0 - - ) • 8 " - - ' 0 3 0 ' ' ;
Page 20 and 21: B ' & - #' ( - ; + B B;; ' ( $ - '
Page 24 and 25: • ) - . 4 ! . ! ,+(( (*+)( )*+& ,
Page 26 and 27: aantal consultaties bij huisarts en
Page 28 and 29: • D < - 0 - 0) & /0 / 1# 1 #' 0 0
Page 30 and 31: ) - - 77 8 8 . . - 8 8 . aantal kla
Page 32 and 33: 1 7 3 0 1 0 0 4' • " # + . 8 8 8
Page 34 and 35: • J - : - 0 + - + - - 3+ 4' ( 0 -
Page 36 and 37: %39& %' • " # D $ / 99 0 - ' #
Page 38 and 39: • " # D ; 0 0 / # - - 99 0 , + +
Page 40 and 41: 1 1 8 (( 2 )+ ' • " # D # / 1 # -
Page 42 and 43: 1 8 ? 1 8 ) :: !! ( - + #'%' 7 '
Page 44 and 45: o C D E P B 99 , R L - 1 S S #' & -
Page 46 and 47: o J % - - , ) - - , , 1 - - , 1; -
Page 48 and 49: 1 @ ! 7 # ' • " # ' N " / - - 1 "
Page 50 and 51: (( %$&8 88 " % ,7*( 1.940 23% 3.18
Page 52 and 53: 3 8 3 3 (5 ) - - 77 - /.// - 3 8 3
Page 54 and 55: - ' #1 1 - ; S 3#
Page 56 and 57: - I S - ' - 2 - + ) - 3 , , 4 - - ,
Page 58 and 59: 0 -- #' -- # " 0 - - / 1" " - " " -
Page 60 and 61: omschreven voorwaarden voor tegemoe
Page 62 and 63: In het revalidatieconcept worden mi
Page 64 and 65: Worden hiermee uit oogpunt van prev
Page 66 and 67: HET VOORSCHRIJVEN VAN HET INDIVIDUE
Page 68 and 69: Artikel 13. §1. De prijzen en hono
Page 70 and 71: Artikel 19. §1. De verantwoordelij
Page 72 and 73:
- - 44 ** ) ( 4 '* # 1 '* -0 - . 77
Page 74 and 75:
11 %% 1 ) # H $ Huisarts 101010 Con
Page 76 and 77:
104436 Visite effectuée par le mé
Page 78 and 79:
1 , 761235 761246 761132 761143 761
Page 80 and 81:
1 1 $ 4 4 @ ! " 3 4 4A . ! " 3 4 49
Page 82 and 83:
A B4 5 !+ 3 " 3 A B C + 3 " 3 < ( 3
Page 84 and 85:
1 8 ? 8 " 3 3 A 3 0 8 " 3 A 115 5 e
Page 86 and 87:
88 %% 8 ) +$ 8 1(9+4- 1(99)1 : 1(94
Page 88 and 89:
8 1 Angiografieën (6')+' (6')9( An
Page 90 and 91:
(24+'' (24+(( Examen duplex couleur
Page 92 and 93:
Amputaties 289951 289962 Amputation
Page 94 and 95:
8 ; - 651755 651770 Prothèse défi
Page 97 and 98:
) !! !! !! ( 0 - - 1 B 1B;;1BPN' 8
Page 99 and 100:
@@ ) - ) - ) - 8 3 + 7HI ! 3 7H8I 8
Page 101 and 102:
FF ## F ) # 4 # ) - . ! ! ! ,+(( (*
Page 103 and 104:
+$ = $#=#= #=CC$= D #D $ # =3 # - #
Page 105 and 106:
G # 4 #! 8 . - . 4 ! . ! ! ! +$ = $
Page 107 and 108:
22 ## >> $$ 2 ) # > $ 4 # ) - . 9 !
Page 109 and 110:
) # $ 4 #! 8 . - . 4 ! . ! - ! ! !
Page 111 and 112:
)))) ?? !! )) ) ! ! 4 # ) - 8 8 . !
Page 113 and 114:
)) ! ! 4 #! 8 . - . 4 ! . 8 8 . ! !
Page 115 and 116:
) 4 #! 8 . - . 4 ! . . ! ! ! + $C $
Page 117 and 118:
) . . ! - - " ! - ' ! ,+(( (*+)( )*
Page 119 and 120:
) . . ! ! 8 " 0% 0% 0% 0% 0% 0% 0%
Page 121 and 122:
) . . ! ! ,+(( (*+)( )*+& , - 1 144
Page 123 and 124:
) . . ! .? ! ,+(( (*+)( )*+& 8 " 0%
Page 125 and 126:
) . . ! ! ,+(( (*+)( 8 " 0% 0% 0% 0
Page 127 and 128:
) . . ! ! ! ,+(( (*+)( )*+& , - 1 1
Page 129 and 130:
) . . ! ; 88 ! ,+(( (*+)( 8 " 0% 1%
Page 131 and 132:
) . . ! - ! ,+(( (*+)( )*+& , - 8 "
Page 133 and 134:
) . . !
Page 135 and 136:
11 ,,CC .. 1 ) C . 4 # ) - .? - - !
Page 137 and 138:
88 8 ) 4 # ) - - . - ! ! ! ,+(( (*+
Page 139 and 140:
(( ) 4 # ) - ! ! ! ,+(( (*+)( )*+&
Page 141 and 142:
@@ :: !! @ ) ! 4 # ) - 8 . " ' ! !
Page 143 and 144:
FF CC CC F ) C C 4 # ) - ? ? . - !
Page 145 and 146:
+ $C $C
Page 147 and 148:
) . . ! ? - ! ,+(( (*+)( )*+& , - 3
Page 149 and 150:
22 CC DD EE 2 ) C D E 4 # ) - ? - -
Page 151 and 152:
+ $C $C
Page 153 and 154:
) . . ! ? . - ! ,+(( (*+)( 3 51% 24
Page 155 and 156:
11)) :: !! 1) ) ! 4 # ) - . 8 " ' !
Page 157 and 158:
11 !! 1 ) ! 4 # %$&8 ! ! ! ,+(( (*+
Page 159 and 160:
) - - 77 - ! + 3 3 8 3 3 ! > > " ;
Page 161:
$ ' 9 9. , V:C ' ! . K . ' F ' P :
show all

Lees - Bvvde

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?